• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,487.86 127.85
( 0.17%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
492.26
15448.12
EPS(TTM)
Face Value()
Div & Yield %
1.97
1
0.51
 

Bajaj Steel Inds slumps after Q4 PAT drops 87% YoY to Rs 2 cr
May 27,2026
Revenue from operations declined 23.93% YoY to Rs 116.76 crore for the quarter ended 31 March 2026.

Profit before tax (PBT) dropped 83.61% YoY to Rs 3.81 crore in Q4 FY26, down from Rs 23.25 crore reported in the same quarter last year.

Total expenses declined 13.31% YoY to Rs 118.54 crore during the quarter. The cost of materials consumed stood at Rs 68.25 crore, down 9.28% YoY, while employee benefit expenses increased 5.81% YoY to Rs 20.58 crore during the period under review.

The board has recommended a final dividend of Rs 1 per equity share of face value Rs 5 each for FY 2025-26, subject to shareholders’ approval at the forthcoming Annual General Meeting (AGM) of the company.

Bajaj Steel Industries is engaged in the manufacturing of cotton ginning and pressing machinery, engineering products, electrical panels, prefabricated building structures, and related equipment. The company operates across various segments of the cotton processing value chain.